bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: O S A J J M A M F J
2016: D N O

 
  Other news for:
Pain
 Resources from HONselect
Addictive Opioids Common for People on Dialysis
But dose of pain-killing drugs often too high, researchers say

By Robert Preidt

THURSDAY, Sept. 21, 2017 (HealthDay News) -- Kidney dialysis patients in the United States have high rates of prescriptions for opioid painkillers and many also receive high doses of the potentially addictive drugs, a new study finds.

Pain is common in dialysis patients, the study authors explained in a news release from the American Society of Nephrology.

But these patients can't take certain drugs because their failing kidneys can't process them. This makes pain control difficult.

For the new study, researchers reviewed Medicare data from 2006 through 2010. The investigators found that nearly two-thirds of dialysis patients received at least one opioid prescription every year. More than 20 percent received repeated prescriptions.

In addition, more than 25 percent of patients given opioid prescriptions received higher-than-recommended doses.

The use of opioids was associated with increased risks of early death, discontinuing dialysis and hospitalization, the findings showed. However, the association seen in the study does not prove a cause-and-effect relationship.

"Excessive opioid use and its adverse outcomes in the end-stage renal [kidney] disease population is of great concern to U.S. patients, practitioners and policy makers," study author Dr. Paul Kimmel, of the U.S. National Institute of Diabetes and Digestive and Kidney Diseases, said in the news release.

"This study shows that this high-risk dialysis population is also subject to the risks of long-term opioid use. Exploring other options to treat pain, such as medications and behavioral therapy, could help reduce opioid prescriptions in this population. Such changes are urgently needed to decrease patient morbidity and mortality," Kimmel concluded.

The study was published online Sept. 21 in the Journal of the American Society of Nephrology.

More information

The National Kidney Foundation has more on dialysis.

SOURCE: American Society of Nephrology, news release, Sept. 21, 2017

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=726646

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Dialysis
Kidney
Pain
Research Personnel
Specialty Chemicals and Products
Risk
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact